Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

21 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Methodology to estimate natural- and vaccine-induced antibodies to SARS-CoV-2 in a large geographic region.
DeSantis SM, León-Novelo LG, Swartz MD, Yaseen AS, Valerio-Shewmaker MA, Talebi Y, Brito FA, Ross JA, Kohl HW 3rd, Messiah SE, Kelder SH, Wu L, Zhang S, Aguillard KA, Gonzalez MO, Omega-Njemnob OS, Lakey D, Shuford JA, Pont S, Boerwinkle E. DeSantis SM, et al. Among authors: shuford ja. PLoS One. 2022 Sep 9;17(9):e0273694. doi: 10.1371/journal.pone.0273694. eCollection 2022. PLoS One. 2022. PMID: 36084125 Free PMC article.
Strategies to Estimate Prevalence of SARS-CoV-2 Antibodies in a Texas Vulnerable Population: Results From Phase I of the Texas Coronavirus Antibody Response Survey.
Valerio-Shewmaker MA, DeSantis S, Swartz M, Yaseen A, Gonzalez MO, Kohl HWI, Kelder SH, Messiah SE, Aguillard KA, Breaux C, Wu L, Shuford J, Pont S, Lakey D, Boerwinkle E. Valerio-Shewmaker MA, et al. Front Public Health. 2021 Dec 14;9:753487. doi: 10.3389/fpubh.2021.753487. eCollection 2021. Front Public Health. 2021. PMID: 34970525 Free PMC article. Clinical Trial.
Durability of SARS-CoV-2 Antibodies From Natural Infection in Children and Adolescents.
Messiah SE, DeSantis SM, Leon-Novelo LG, Talebi Y, Brito FA, Kohl HW, Valerio-Shewmaker MA, Ross JA, Swartz MD, Yaseen A, Kelder SH, Zhang S, Omega-Njemnobi OS, Gonzalez MO, Wu L, Boerwinkle E, Lakey DL, Shuford JA, Pont SJ. Messiah SE, et al. Among authors: shuford ja. Pediatrics. 2022 Jun 1;149(6):e2021055505. doi: 10.1542/peds.2021-055505. Pediatrics. 2022. PMID: 35301530 No abstract available.
Antibody Duration After Infection From SARS-CoV-2 in the Texas Coronavirus Antibody Response Survey.
Swartz MD, DeSantis SM, Yaseen A, Brito FA, Valerio-Shewmaker MA, Messiah SE, Leon-Novelo LG, Kohl HW, Pinzon-Gomez CL, Hao T, Zhang S, Talebi Y, Yoo J, Ross JR, Gonzalez MO, Wu L, Kelder SH, Silberman M, Tuzo S, Pont SJ, Shuford JA, Lakey D, Boerwinkle E. Swartz MD, et al. Among authors: shuford ja. J Infect Dis. 2023 Jan 11;227(2):193-201. doi: 10.1093/infdis/jiac167. J Infect Dis. 2023. PMID: 35514141 Free PMC article.
Comparison of Persistent Symptoms Following SARS-CoV-2 Infection by Antibody Status in Nonhospitalized Children and Adolescents.
Messiah SE, Hao T, DeSantis SM, Swartz MD, Talebi Y, Kohl HW 3rd, Zhang S, Valerio-Shewmaker M, Yaseen A, Kelder SH, Ross J, Gonzalez MO, Wu L, Padilla LN, Lopez KR, Lakey D, Shuford JA, Pont SJ, Boerwinkle E. Messiah SE, et al. Among authors: shuford ja. Pediatr Infect Dis J. 2022 Oct 1;41(10):e409-e417. doi: 10.1097/INF.0000000000003653. Epub 2022 Aug 1. Pediatr Infect Dis J. 2022. PMID: 35939608
Incidence and Predictors of Breakthrough and Severe Breakthrough Infections of SARS-CoV-2 After Primary Series Vaccination in Adults: A Population-Based Survey of 22 575 Participants.
DeSantis SM, Yaseen A, Hao T, León-Novelo L, Talebi Y, Valerio-Shewmaker MA, Pinzon Gomez CL, Messiah SE, Kohl HW, Kelder SH, Ross JA, Padilla LN, Silberman M, Tuzo S, Lakey D, Shuford JA, Pont SJ, Boerwinkle E, Swartz MD. DeSantis SM, et al. Among authors: shuford ja. J Infect Dis. 2023 May 12;227(10):1164-1172. doi: 10.1093/infdis/jiad020. J Infect Dis. 2023. PMID: 36729177
Case Report: Paucisymptomatic College-Age Population as a Reservoir for Potentially Neutralization-Resistant Severe Acute Respiratory Syndrome Coronavirus 2 Variants.
Neuman BW, Brashear WA, Brun M, Chaki SP, Fischer RSB, Guidry SJ, Hill JE, Hillhouse AE, Johnson CD, Kahl-McDonagh MM, Metz RP, Rice-Ficht AC, Shuford JA, Skaggs TA, Stull MA, Threadgill DW, Akpalu Y, Zuelke K. Neuman BW, et al. Among authors: shuford ja. Am J Trop Med Hyg. 2021 Sep 20;105(5):1227-1229. doi: 10.4269/ajtmh.21-0542. Am J Trop Med Hyg. 2021. PMID: 34544043 Free PMC article.
Use of Drug-level Testing and Single-genome Sequencing to Unravel a Case of Human Immunodeficiency Virus Seroconversion on Pre-exposure Prophylaxis.
Spinelli MA, Lowery B, Shuford JA, Spindler J, Kearney MF, McFarlane JR, McDonald C, Okochi H, Phung N, Kuncze K, Jee K, Johannessen D, Anderson PL, Smith DK, Defechereux P, Grant RM, Gandhi M. Spinelli MA, et al. Among authors: shuford ja. Clin Infect Dis. 2021 Jun 1;72(11):2025-2028. doi: 10.1093/cid/ciaa1011. Clin Infect Dis. 2021. PMID: 32686825 Free PMC article.
21 results